1-1 of 1
Claire Baker, BSc
Close
Sort by
Journal Articles

The Novel PARP Inhibitor, AZD2281, Targets Apoptotic Resistant ATM Mutant CLL Tumours for Cellular Killing.

Victoria Weston, PhD, Claire Baker, BSc, Belinda Austen, BMBCh, Malcolm Taylor, PhD, Paul Moss, PhD, Tanja Stankovic, PhD
Journal: Blood
Blood (2006) 108 (11): 2110.
https://doi.org/10.1182/blood.V108.11.2110.2110
Published: 2006